MedPath

Glycemic Load & Resistance Training on Endothelial Function & Insulin Sensitivity

Not Applicable
Completed
Conditions
160 Participants Aged 18-35 Years and Obese (BMI ≥30) Open to Men and Women of All Ethnicity
Interventions
Other: Glycemic Load
Other: Resistance Training
Registration Number
NCT01755962
Lead Sponsor
University of California, Los Angeles
Brief Summary

This project is prompted by the urgent public health need to identify novel strategies to prevent cardiovascular disease (CVD) and type 2 diabetes (T2D). The higher prevalence of CVD, T2D, and metabolic syndrome in obese individuals is a major healthcare concern. Therefore, finding optimal intervention strategies to combat these growing epidemics is imperative.

Detailed Description

At present, the extent to which dietary components can modify endothelial function, monocyte inflammation and glycemic variations is not well defined, although different carbohydrates are known to vary in their abilities to induce plasma glucose and insulin responses. Epidemiologic work suggests that high dietary glycemic load (GL) is associated with increased concentrations of inflammatory cytokines, endothelial dysfunction markers, and increased risk of T2D and coronary heart disease (CHD). We are examining using randomized control trials low vs. high-GL diet to determine if low-GL diets induce improvements in endothelial function or monocyte inflammation. Furthermore, resistance training is an alternate form of exercise from conventional aerobic training. Resistance Training has the potential to improve endothelial function or monocyte phenotype, but there is very little data in this area. We hypothesize that resistance training may augment the beneficial effects of a low-GL diet in improving metabolic health.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
88
Inclusion Criteria
  • 18-35 with BMI≥30 and/or your waist circumference ≥40 inches for males or ≥35 inches for females
  • In good health as determined by the screening visit and review of medical history
Read More
Exclusion Criteria
  • Have a known heart arrhythmia and/or abnormalities found in electrocardiogram (ECG) reading or use of medications that influence CV function
  • Have been in a weight loss or exercise program in the 6 months prior to participation
  • Use tobacco products
  • Have a syndrome or are prescribed medications that may influence body composition, insulin action, or CVD (e.g. PCOS, prednisone, methylphenidate, etc.)
  • Have intolerance to lactose or gluten
  • Pregnant
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
FACTORIAL
Arm && Interventions
GroupInterventionDescription
High Glycemic Load + Resistance TrainingResistance Training12-week control diet + resistance training (1 hour, 3 times per week)
Low Glycemic Load + Resistance TrainingGlycemic Load12-week intervention diet + resistance training (1 hour, 3 times per week)
Low Glycemic Load + Resistance TrainingResistance Training12-week intervention diet + resistance training (1 hour, 3 times per week)
High Glycemic LoadGlycemic Load12-week control diet
High Glycemic Load + Resistance TrainingGlycemic Load12-week control diet + resistance training (1 hour, 3 times per week)
Low Glycemic LoadGlycemic Load12-week intervention diet
Primary Outcome Measures
NameTimeMethod
Endothelial function as determined by brachial artery FMD12 weeks
Secondary Outcome Measures
NameTimeMethod
monocyte inflammation12 weeks
Insulin Sensitivity by Oral Glucose Tolerance Test12 weeks
MAGE via Continuous Glucose Monitoring System12 weeks

Trial Locations

Locations (1)

University of California, Los Angeles

🇺🇸

Los Angeles, California, United States

© Copyright 2025. All Rights Reserved by MedPath